一个内质网膜压力特定的纳米诱导器选择性地唤起II型免疫细胞死亡,用于皮罗普托斯癌症免疫疗法
Yimeng Zhang1,2,3, Yue Yan4, Jianxiong Liu3
1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
Advanced materials (Deerfield Beach, Fla.)
|May 28, 2025
概括
研究人员开发了一种新的纳米平台 (PCANER),专门诱导内分泌网膜 (ER) 应激和II型免疫细胞死亡 (ICD),用于增强癌症免疫疗法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 细胞内膜网膜 (ER) 应激启动的II型免疫细胞死亡 (ICD) 对癌症免疫疗法具有前途.
- 选择性诱导II型ICD受到低效的ER向策略的阻碍.
研究的目的:
- 开发一个pH/Cathepsin-Activatable纳米平台 (PCAN),用于特定的ER应激和II型ICD的光诱导.
- 在癌症治疗中研究ER向型II型ICD与 lysosome向型I型ICD的疗效.
主要方法:
- 设计了一种双门纳米平台 (PCAN),具有用于ER准的长循环特性.
- 评估了ER针对癌症组织的有效性和局部化.
- 通过葡萄糖调节蛋白78和calreticulin暴露来评估ER压力,II型ICD和火病的诱导.
- 将PCANER (针对ER的) 与PCANLy (针对溶酶体) 的抗瘤疗效进行比较.
主要成果:
- PCANER表现出了优秀的ER向,在癌症组织中具有83%的局部化.
- PCANER有效地加剧了ER压力,促进了II型ICD和热,导致显著的免疫原始化.
- 色素向PCANLy诱导轻度I型ICD,抗瘤效果微不足道.
- 该研究实现了用于癌症治疗的ICD类型和pyroptosis的精确调整.
结论:
- 通过PCAN技术,可以空间时空控制亚细胞器官的向,以调节细胞死亡机制.
- 针对ER压力诱导II型ICD提供了一个有希望的策略,以促进癌症免疫治疗.
- 这项工作为设计用于癌症治疗的有机细胞水平向纳米药物提供了新的见解.
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
The Extrinsic Apoptotic Pathway
6.7K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.7K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Cells of the Innate Immune Response
3.9K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
3.9K
Overview of Cell Death
7.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.8K


